Sleep Apnea Diagnostic Alternatives Still Not Up To PSG Gold Standard
This article was originally published in The Gray Sheet
Executive SummaryWhile overnight full-channel polysomnography (PSG) for diagnosis of sleep apnea remains superior to other techniques, several less expensive and less time consuming tests "appear promising," according to a recent literature review published by the Agency for Health Care Policy and Research.
You may also be interested in...
TTS Pharma CEO Mark Tucker discusses his ambition to bring a legal CBD oil to the UK market, following the recent submission of a European Union novel food application.
Italy Round-Up: Mylan And Polifarma Strike Deal, OTC Market Stable, Cholesterol-Lowering Probiotic Launch
The latest news from Italy's OTC and supplements markets, including the latest sales figures, business deals, product launches, ad regulation and local association activities.
Sandoz CEO Richard Saynor has pledged that the company will ensure stable pricing for essential coronavirus-related medicines amid concerns over how the outbreak will affect the supply chain.